CG
BPMC

Cutler Group’s Blueprint Medicines BPMC Stock Holding History

Cutler Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,500
Closed -$33K – 3808
2023
Q2 		$33K Buy
+2,500
New +$136K ﹤0.01% 1545
2022
Q2 		– Sell
-4,000
Closed -$17K – 4986
2022
Q1 		$17K Buy
+4,000
New +$287K ﹤0.01% 3178
2021
Q1 		– Sell
-6,000
Closed -$88K – 5645
2020
Q4 		$88K Hold
6,000
– – ﹤0.01% 1611
2020
Q3 		$46K Buy
+6,000
New +$462K ﹤0.01% 1844
2019
Q4 		– Sell
-7,800
Closed -$5K – 3992
2019
Q3 		$5K Buy
7,800
+7,700
+7,700% +$666K ﹤0.01% 2988
2019
Q2 		$1K Sell
100
-200
-67% -$16.5K ﹤0.01% 3782
2019
Q1 		$2K Buy
+300
New +$22.2K ﹤0.01% 3335
2018
Q4 		– Sell
-100
Closed -$1K – 3950
2018
Q3 		$1K Buy
+100
New +$6.95K ﹤0.01% 3703
2018
Q2 		– Sell
-4,300
Closed -$32K – 4214
2018
Q1 		$32K Buy
4,300
+200
+5% +$17.2K ﹤0.01% 1960
2017
Q4 		$21K Buy
4,100
+3,700
+925% +$260K ﹤0.01% 2511
2017
Q3 		$10K Sell
400
-1,900
-83% -$102K ﹤0.01% 3786
2017
Q2 		$25K Sell
2,300
-7,700
-77% -$327K ﹤0.01% 3179
2017
Q1 		$24K Buy
10,000
+2,900
+41% +$104K ﹤0.01% 3132
2016
Q4 		$6K Sell
7,100
-1,900
-21% -$57.3K ﹤0.01% 4711
2016
Q3 		$46K Buy
+9,000
New +$224K ﹤0.01% 2542

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Cutler Group's BPMC Position: Q4 2023 in Review

Cutler Group sold out of Blueprint Medicines (BPMC) in Q4 2023, closing a stake of 1,000 shares — an estimated $50K sold.

Cutler Group first reported a position in BPMC in Q1 2017 and held it in 21 quarters. The position peaked at $456K in Q1 2017. 259 funds tracked by Wall St. Rank hold BPMC as of Q4 2023.

  • Cutler Group reported no remaining Blueprint Medicines position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,000 Blueprint Medicines shares in Q4 2023, an estimated $50K.
  • Cutler Group first reported a position in Blueprint Medicines in Q1 2017 and held it in 21 quarters.
  • Cutler Group's Blueprint Medicines position peaked at $456K in Q1 2017.
  • 259 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.